(MedPage Today) — Familiarity with healthcare information technology (HIT) and electronic records systems may soon be part of the specialist board certification process, the American Board of Medical Specialties (ABMS) announced.
No Comments »
Filed under: General Health News
(MedPage Today) — An FDA advisory committee will meet Wednesday to decide whether to recommend approval of ezogabine (Potiva) for adjunctive treatment of partial-onset seizures in epilepsy patients.
No Comments »
Filed under: General Health News
(MedPage Today) — The rate of cases of invasive healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections declined over a recent four-year period, researchers found.
No Comments »
Filed under: General Health News
(MedPage Today) — Per capita emergency room (ER) utilization jumped 11% from 1997 to 2007, with adult Medicaid patients accounting for virtually all the growth, researchers said.
No Comments »
Filed under: General Health News
(MedPage Today) — Director-General of the World Health Organization Margaret Chan, MD, MPH, has declared an end to the H1N1 influenza pandemic, following the advice of an emergency committee convened to address the issue.
No Comments »
Filed under: General Health News
Vertex Pharmaceuticals Incorporated today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).
No Comments »
Filed under: Pharmacy News
China Pharma Holdings, Inc., a leading fully-integrated specialty pharmaceuticals company in China, today announced financial results for the second quarter ended June 30, 2010.
No Comments »
Filed under: Pharmacy News
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride [...]
No Comments »
Filed under: Pharmacy News
New study findings showed that a majority of patients with moderate to severe plaque psoriasis who had a previous response to STELARA® (ustekinumab) sustained a clinical response for up to three years with continued treatment regardless of their body weight. Investigators also presented findings from an integrated safety analysis that included data from one Phase [...]
No Comments »
Filed under: Pharmacy News
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and six months ended June 30, 2010.
No Comments »
Filed under: Pharmacy News
